BEAM
Price
$28.59
Change
-$1.18 (-3.96%)
Updated
Nov 29, 6:59 PM EST
90 days until earnings call
MNKD
Price
$3.54
Change
+$0.04 (+1.14%)
Updated
Nov 29, 6:59 PM EST
90 days until earnings call
Ad is loading...

Compare predictions BEAM vs MNKD

Header iconBEAM vs MNKD Comparison
Open Charts BEAM vs MNKDBanner chart's image
Beam Therapeutics
Price$28.59
Change-$1.18 (-3.96%)
Volume$892.19K
CapitalizationN/A
MannKind
Price$3.54
Change+$0.04 (+1.14%)
Volume$1.07M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs MNKD Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BEAM vs. MNKD commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and MNKD is a Sell.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (BEAM: $28.59 vs. MNKD: $3.50)
Brand notoriety: BEAM and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 64% vs. MNKD: 84%
Market capitalization -- BEAM: $2.38B vs. MNKD: $948.9M
BEAM [@Biotechnology] is valued at $2.38B. MNKD’s [@Biotechnology] market capitalization is $948.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 2 green, 3 red.
According to our system of comparison, MNKD is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while MNKD’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • MNKD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than MNKD.

Price Growth

BEAM (@Biotechnology) experienced а -2.99% price change this week, while MNKD (@Biotechnology) price change was -5.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.60%. For the same industry, the average monthly price growth was +37.65%, and the average quarterly price growth was +9.10%.

Reported Earning Dates

BEAM is expected to report earnings on Feb 27, 2024.

MNKD is expected to report earnings on Feb 27, 2024.

Industries' Descriptions

@Biotechnology (+4.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for MNKD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($2.38B) has a higher market cap than MNKD($949M). BEAM YTD gains are higher at: -26.898 vs. MNKD (-33.586). MNKD has higher annual earnings (EBITDA): 2.24M vs. BEAM (-379.73M). BEAM has more cash in the bank: 1.02B vs. MNKD (141M). BEAM has less debt than MNKD: BEAM (173M) vs MNKD (278M). MNKD has higher revenues than BEAM: MNKD (177M) vs BEAM (81.6M).
BEAMMNKDBEAM / MNKD
Capitalization2.38B949M250%
EBITDA-379.73M2.24M-16,930%
Gain YTD-26.898-33.58680%
P/E RatioN/AN/A-
Revenue81.6M177M46%
Total Cash1.02B141M720%
Total Debt173M278M62%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMNKD
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLLCX9.920.07
+0.71%
abrdn Emerging Markets ex-China C
FAOFX12.150.04
+0.33%
Fidelity Advisor® Series Growth Opps
RSOOX33.420.06
+0.18%
Columbia Dividend Opportunity R
TRULX34.40-0.09
-0.26%
T. Rowe Price US Large-Cap Core
RCMPX14.74-0.04
-0.27%
Lazard International Quality Gr R6